Homepage
Medication Guide
What Are the Side Effects of Astomin (Dimemorfan Phosphate Tablets)?
Astomin (Dimemorfan Phosphate Tablets) is a non-narcotic central antitussive. Since its launch in Japan in 1975, it has been widely used to relieve cough symptoms in adults due to its low side effects...
506
Monday, November 17th, 2025, 11:09
Dosage and Administration of Astomin (Dimemorfan Phosphate Tablets)
Astomin (Dimemorfan Phosphate Tablets) is a non-narcotic central antitussive. First approved in Japan in 1974, it has been widely used for relieving cough symptoms due to its high safety and low abuse...
508
Monday, November 17th, 2025, 10:58
Dosage and Administration of Xphozah (Tenapanor)
Xphozah (Tenapanor) is an FDA-approved sodium-hydrogen exchanger 3 (NHE3) inhibitor specifically indicated for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) undergoi...
506
Monday, November 17th, 2025, 10:55
What Are the Indications for Xphozah (Tenapanor)?
Xphozah (Tenapanor) is an innovative medication approved by the U.S. Food and Drug Administration (FDA), providing a new treatment option for serum phosphorus control in patients with chronic kidney d...
506
Monday, November 17th, 2025, 10:50
Purchase Channels for Xphozah (Tenapanor)
Xphozah (Tenapanor) is a sodium-hydrogen exchanger 3 (NHE3) inhibitor with tenapanor hydrochloride as the active ingredient. First approved in the United States in 2019, this medication is primarily u...
501
Monday, November 17th, 2025, 09:58
Side Effects of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch system containing 8% capsaicin, indicated for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and diabetic peripheral neurop...
504
Monday, November 17th, 2025, 09:49
What Are the Precautions for Using Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a transdermal drug delivery system containing 8% capsaicin (640 micrograms per square centimeter), which was first approved in the United States in 2009. As a TRPV1 channe...
504
Monday, November 17th, 2025, 09:37
Dosage and Administration of Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is an FDA-approved topical medication for the treatment of postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN). Its unique ...
504
Monday, November 17th, 2025, 09:33
What Are the Indications for Qutenza (Capsaicin Patch)?
Qutenza (Capsaicin Patch) is a therapeutic medication approved by the U.S. Food and Drug Administration (FDA), providing an innovative treatment option for patients with specific types of neuropathic ...
503
Monday, November 17th, 2025, 09:28
Purchase Channels for Qutenza (Capsaicin Patch)
Qutenza (Capsaicin Patch) is a topical patch containing 8% capsaicin, classified as a TRPV1 channel agonist. In July 2020, this medication was approved by the U.S. FDA for the treatment of foot neural...
505
Monday, November 17th, 2025, 09:24
48 / 200
1996 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved